Research outputs

Publications

All peer-reviewed publications till date

Filter by fieldAll Precision medicine Rare diseases Psychoactive drugs Other

2026Effectiveness and tolerability of cannabidiol in paediatric epilepsy: a one-year multisite prospective studyHalman, A, Freeman, J, Fahey, M, Chenhall, R, Perkins, DEpilepsy & Behavior, doi: 10.1016/j.yebeh.2026.111095Psychoactive Drugs 2026Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug DevelopmentHalman, A, Corriden, RPharmacology Research & Perspectives, doi: 10.1002/prp2.70309Psychoactive Drugs 2025Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 studyPerkins, D, Halman, A, Urokohara, A, Palumbo, J, Low, M, Ruffell, S, Galvão-Coelho, N, Collins, L, Norman, A, Sarris, JScientific Reports, doi: 10.1038/s41598-025-25767-xPsychoactive Drugs 2025Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca ConsumptionPagni, B, Halman, A, Sarris, J, Chenhall, R, Bogenschutz, M, Perkins, DJournal of Psychoactive Drugs, doi: 10.1080/02791072.2025.2465800Psychoactive Drugs 2025Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted TherapyHalman, A, Conyers, R, Moore, C, Khatri, D, Sarris, J, Perkins, DClinical Pharmacology & Therapeutics, doi: 10.1002/cpt.3459Psychoactive Drugs 2025Changes in Pain and Mental Health Symptoms Associated with Prescribed Medicinal Cannabis Use: A One-Year Longitudinal StudyHalman, A, Chenhall, R, Perkins, DJournal of Pain and Palliative Care Pharmacotherapy, doi: 10.1080/15360288.2024.2414898Psychoactive Drugs 2024Drug-drug interactions involving classic psychedelics: A systematic reviewHalman, A, Kong, G, Sarris, J, Perkins, DJournal of Psychopharmacology, doi: 10.1177/02698811231211219Psychoactive Drugs 2024Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global DatasetPerkins, D, Sarris, J, Cowley-Court, T, Aicher, H, Tófoli, L, Carlos Bouso, J, Opaleye, E, Halman, A, Galvão-Coelho, N, Schubert, VJournal of Psychoactive Drugs, doi: 10.1080/02791072.2024.2424288Psychoactive Drugs 2024Artificial intelligence and psychedelic medicineSarris, J, Halman, A, Urokohara, A, Lehrner, M, Perkins, DAnnals of the New York Academy of Sciences, doi: 10.1111/nyas.15229Psychoactive Drugs 2023Ayahuasca: A review of historical, pharmacological, and therapeutic aspectsRuffell, S, Crosland‐Wood, M, Palmer, R, Netzband, N, Tsang, W, Weiss, B, Gandy, S, Cowley‐Court, T, Halman, A, McHerron, D, Jong, A, Kennedy, T, White, E, Perkins, D, Terhune, D, Sarris, JPsychiatry and Clinical Neurosciences Reports, doi: 10.1002/pcn5.146Psychoactive Drugs 2017Prefrontal cortical control of a brainstem social behavior circuitFranklin, T, Silva, B, Perova, Z, Marrone, L, Masferrer, M, Zhan, Y, Kaplan, A, Greetham, L, Verrechia, V, Halman, A, Pagella, S, Vyssotski, A, Illarionova, A, Grinevich, V, Branco, T, Gross, CNature Neuroscience, doi: 10.1038/nn.4470Psychoactive Drugs